Stryker Corporation

NYSE: SYK · Real-Time Price · USD
377.92
3.93 (1.05%)
At close: May 02, 2025, 3:59 PM
375.97
-0.52%
Pre-market: May 05, 2025, 05:19 AM EDT
1.05%
Bid 366.5
Market Cap 144.25B
Revenue (ttm) 23.22B
Net Income (ttm) 2.86B
EPS (ttm) 7.74
PE Ratio (ttm) 48.83
Forward PE 25.19
Analyst Buy
Ask 385.13
Volume 3,264,186
Avg. Volume (20D) 1,604,642.3
Open 375.73
Previous Close 373.99
Day's Range 363.08 - 379.32
52-Week Range 314.93 - 406.19
Beta 0.94

About SYK

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and...

Sector Healthcare
IPO Date Mar 17, 1980
Employees 53,000
Stock Exchange NYSE
Ticker Symbol SYK
Full Company Profile

Analyst Forecast

According to 19 analyst ratings, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $435, which is an increase of 15.10% from the latest price.

Stock Forecasts

Earnings Surprise

Stryker has released their quartely earnings on May 1, 2025:
  • Revenue of $5.87B exceeds estimates by $166M, with 11.88% YoY growth.
  • EPS of 2.84 exceeds estimates by 0.14, with 13.60% YoY growth.
  • 3 days ago
    +1.13%
    SYK stock has given up its prior loss. Stryker sha... Unlock content with Pro Subscription
    3 days ago
    +1.13%
    Stryker shares are trading lower after the company cut its FY25 adjusted EPS guidance and Evercore ISI group lowered its price target on the stock from $400 to $390.